Covered recipient · General Payments record
SUKHPREET KAUR
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2022
$435.20
- Reported across 23 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $215.42 | 11 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $56.65 | 3 |
| Biofrontera Inc. | $44.17 | 2 |
| LEO Pharma Inc. | $26.84 | 1 |
| Amgen Inc. | $25.60 | 1 |
| ABBVIE INC. | $25.20 | 2 |
| Janssen Biotech, Inc. | $18.57 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $18.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.94 | 01/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892089911 | CMS |
| ABBVIE INC. | $12.26 | 02/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892089913 | CMS |
| Amgen Inc. | $25.60 | 04/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | 940013743 | CMS |
| Biofrontera Inc. | $22.98 | 04/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | 928734101 | CMS |
| Biofrontera Inc. | $21.19 | 04/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 928734125 | CMS |
| Janssen Biotech, Inc. | $18.57 | 04/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 885597777 | CMS |
| LEO Pharma Inc. | $26.84 | 05/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | 936355471 | CMS |
| Lilly USA, LLC | $17.02 | 01/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918719293 | CMS |
| Lilly USA, LLC | $20.64 | 03/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918719297 | CMS |
| Lilly USA, LLC | $18.99 | 04/27/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918630121 | CMS |
| Novartis Pharmaceuticals Corporation | $18.39 | 03/29/2022 | Food and Beverage | Undisputed | 01/23/2026 | 894610273 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022
- Source files
- Dataset page · Bulk file · PY2021 , PY2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.